PYGL Inhibitors

1,4-Dideoxy-1,4-imino-D-arabinitol hydrochloride acts as a potent inhibitor of glycogen phosphorylase, influencing glycogen metabolism. Its structural conformation allows for specific binding to the enzyme's active site, disrupting substrate access and altering reaction kinetics. This compound exhibits unique molecular interactions that stabilize the enzyme-inhibitor complex, effectively modulating enzymatic activity. Its solubility properties facilitate efficient distribution in biochemical assays, enhancing experimental versatility.

BAY-876 is a selective and potent chemical inhibitor targeting the glycogen phosphorylase (PYGL). It directly inhibits the enzyme's catalytic activity, preventing the conversion of glycogen to glucose-1-phosphate. By blocking PYGL, BAY-876 disrupts the glycogenolysis pathway, ultimately reducing the availability of glucose for energy production.

CP-91149 is a selective inhibitor of glycogen phosphorylase, characterized by its unique ability to form stable interactions with the enzyme's allosteric site. This compound alters the enzyme's conformational dynamics, leading to a significant reduction in catalytic efficiency. Its distinct molecular architecture promotes specific hydrogen bonding and hydrophobic interactions, enhancing binding affinity. Additionally, CP-91149's solubility profile supports its effective integration into various biochemical systems, allowing for precise modulation of glycogen metabolism.

Bisindolylmaleimide I is a chemical compound known to inhibit glycogen phosphorylase (PYGL). It directly interacts with the enzyme, interfering with its catalytic activity and disrupting the glycogenolysis pathway.

CP-471474 is a PYGL inhibitor that directly interferes with the enzyme′s catalytic activity. By disrupting the glycogenolysis pathway, CP-471474 inhibits the conversion of glycogen to glucose-1-phosphate.